Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) PT at $2.77

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have received a consensus recommendation of “Hold” from the eight analysts that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $2.7667.

A number of equities research analysts have issued reports on DH shares. Zacks Research upgraded shares of Definitive Healthcare from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. Canaccord Genuity Group cut their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating for the company in a research report on Friday, February 27th. Barclays cut their price target on shares of Definitive Healthcare from $2.75 to $1.00 and set an “underweight” rating on the stock in a report on Monday, March 30th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, March 14th.

Definitive Healthcare Stock Up 3.6%

DH stock opened at $0.87 on Wednesday. Definitive Healthcare has a 12-month low of $0.81 and a 12-month high of $4.70. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.81. The company has a market cap of $91.92 million, a price-to-earnings ratio of -0.54, a PEG ratio of 73.48 and a beta of 1.34. The company has a 50 day moving average of $1.04 and a two-hundred day moving average of $1.86.

Definitive Healthcare (NASDAQ:DH) last released its earnings results on Thursday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. Definitive Healthcare had a negative net margin of 76.04% and a positive return on equity of 4.04%. The company had revenue of $55.93 million during the quarter, compared to the consensus estimate of $55.02 million. Definitive Healthcare has set its Q2 2026 guidance at 0.030-0.040 EPS and its FY 2026 guidance at 0.160-0.19 EPS. On average, equities analysts anticipate that Definitive Healthcare will post 0.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Goldman Sachs Group Inc. raised its holdings in shares of Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock valued at $25,191,000 after purchasing an additional 7,404,363 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Definitive Healthcare by 1.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,073,197 shares of the company’s stock valued at $8,417,000 after purchasing an additional 33,612 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of Definitive Healthcare by 11.7% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,216,007 shares of the company’s stock valued at $4,937,000 after purchasing an additional 127,055 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of Definitive Healthcare by 23.7% during the 2nd quarter. Bank of America Corp DE now owns 769,397 shares of the company’s stock valued at $3,001,000 after purchasing an additional 147,599 shares in the last quarter. Finally, Inspire Investing LLC raised its holdings in shares of Definitive Healthcare by 505.7% during the 4th quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock valued at $2,006,000 after purchasing an additional 583,562 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.